z-logo
Premium
The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS
Author(s) -
Alkharabsheh Omar,
AlKali Aref,
Saadeh Salwa,
He Rong,
Viswanatha David,
Greipp Patricia,
Reichard Kaaren,
Shah Mithun,
Gangat Naseema,
Patnaik Mrinal,
Hogan William,
Litzow Mark,
Alkhateeb Hassan,
Nguyen Phuong L.
Publication year - 2018
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25239
Subject(s) - myelodysplastic syndromes , medicine , myeloid , bone marrow , myeloid leukemia , leukemia , immunology , oncology

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here